Track 18: Pharmacology and Therapeutic Innovations

Advances in pharmacology continue to transform the management of diabetes and endocrine disorders. This track will explore emerging medications, therapeutic approaches, and innovative drug development strategies. Discussions will focus on improving treatment effectiveness and patient safety. Experts will highlight future directions in endocrine pharmacotherapy.

• GLP-1 Receptor Agonists

• SGLT2 Inhibitors

• Novel Drug Development

• Advanced Therapeutic Strategies

    Related Conference of Track 18: Pharmacology and Therapeutic Innovations

    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France
    October 20-21, 2026

    32nd World Diabetes & Heart Congress

    Amsterdam, Netherlands
    October 22-23, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    February 25-26, 2027

    20th International Summit on Diabetes

    London, UK
    March 23-24, 2027

    7th Annual Summit on Diabetes and Endocrinology

    Paris, France
    March 29-30, 2027

    8th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands

    Track 18: Pharmacology and Therapeutic Innovations Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in